Market Cap Chart

Historical Market Cap Data

View and export this data back to 2011. Start Trial.
Date Value
November 17, 2026 1.000M
November 16, 2026 1.000M
November 13, 2026 1.000M
November 12, 2026 1.000M
November 11, 2026 1.000M
November 10, 2026 1.000M
November 09, 2026 1.000M
November 06, 2026 1.000M
November 05, 2026 1.000M
November 04, 2026 1.000M
November 03, 2026 1.000M
November 02, 2026 1.000M
October 30, 2026 1.000M
October 29, 2026 1.000M
October 28, 2026 1.000M
October 27, 2026 1.000M
October 26, 2026 1.000M
October 23, 2026 1.000M
October 22, 2026 1.000M
October 21, 2026 1.000M
October 20, 2026 1.000M
October 19, 2026 1.000M
October 16, 2026 1.000M
October 15, 2026 1.000M
October 14, 2026 1.000M
Date Value
October 13, 2026 1.000M
October 12, 2026 1.000M
October 09, 2026 1.000M
October 08, 2026 1.000M
October 07, 2026 1.000M
October 06, 2026 1.000M
October 05, 2026 1.000M
October 02, 2026 1.000M
October 01, 2026 1.000M
September 30, 2026 1.000M
September 29, 2026 1.000M
September 28, 2026 1.000M
September 25, 2026 1.000M
September 24, 2026 1.000M
September 23, 2026 1.000M
September 22, 2026 1.000M
September 21, 2026 1.000M
September 18, 2026 1.000M
September 17, 2026 1.000M
September 16, 2026 1.000M
September 15, 2026 1.000M
September 14, 2026 1.000M
September 11, 2026 1.000M
September 10, 2026 1.000M
September 09, 2026 1.000M

Market Capitalization Definition

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.

Read full definition.

Market Cap Range, Past 5 Years

View Market Cap Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Market Cap Benchmarks

View Market Cap Benchmarks
Start Trial
CureVac NV 1.049B
PAION AG 0.3888M
Anbio Biotechnology 160.64M
Anika Therapeutics, Inc. 182.43M
Perspective Therapeutics, Inc. 89.05M

Market Cap Related Metrics

PS Ratio 23.16
Price to Book Value 0.4589
Price 1.12
Earnings Yield -27.75%